You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

COVID-19; SARS-CoV-2

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19 Patients - The Coronavirus Related Outpatient Work

Completed
  • Covid-19 (SARS-CoV-2)
    • New Hyde Park, New York
      410 Lakeville Road, Suite 107
    Jul 13, 2022

    COVID-19: SARS-CoV-2-CZ-PREVAL-II Study

    Completed
    • COVID-19
    • SARS-CoV-2 Infection
    • Quantitative analysis of SARS-CoV-2 antibodies
    • Cellular immunity
    • Prague, Czechia
      Institute of Health Information and Statistics of the Czech Repu
    Nov 25, 2022

    SARS-CoV-2 Infection, COVID-19 Recurrent, Cognitive Dysfunction Trial in Vigo, Ourense (COPERIA-REHAB)

    Not yet recruiting
    • SARS-CoV-2 Infection
    • +3 more
    • COPERIA-REHAB
    • Vigo, Pontevedra, Spain
    • +3 more
    Nov 28, 2022

    ME/CFS, SARS CoV 2 Infection, Fatigue Syndrome, Chronic Trial in München

    Recruiting
    • ME/CFS
    • +3 more
      • München, Germany
        München Klinik Schwabing
      Mar 20, 2023

      Covid19, SARS-CoV Infection Trial in Rochester (Fisetin, Placebo)

      Enrolling by invitation
      • Covid19
      • SARS-CoV Infection
      • Rochester, Minnesota
        Mayo Clinic
      Jan 23, 2023

      COVID19-OR (SARS-CoV-2): Observation,Risk & Recovery

      Completed
      • Exploring Risk Assessment and Recovery From COVID-19 Infection in Hospitalised Patients
        • Worthing, United Kingdom
          Dr Luke Hodgson
        Jul 15, 2022

        CPAP Observance During the COVID-19 (SARS-CoV-2) Pandemic

        Completed
        • Sleep Apnea Syndromes
          • Montpellier, France
            Adene Group
          Mar 7, 2022

          Covid-19; SARS-Cov2 Trial (Blood sampling, Nasal Brushing)

          Not yet recruiting
          • Covid-19; SARS-Cov2
          • Blood sampling
          • Nasal Brushing
          • (no location specified)
          Oct 24, 2022

          DoD Health System

          Not yet recruiting
          • COVID-19; SARS-CoV-2; 2019 Novel Coronavirus Disease
          • (no location specified)
          Oct 4, 2022

          COVID-19, SARS-CoV-2 Trial in Fukuoka-shi (AZD3152 (Cohort 1), Placebo (Cohort 1), AZD3152 (Cohort 2))

          Not yet recruiting
          • COVID-19, SARS-CoV-2
          • AZD3152 (Cohort 1)
          • +5 more
          • Fukuoka-shi, Japan
            Research Site
          Jun 27, 2023

          COVID-19, Post-COVID-19 Syndrome, Influenza Trial in Kunming (Autonomous Treatment System for Covid-19, Post-Acute Sequelae of

          Enrolling by invitation
          • COVID-19
          • +2 more
          • Autonomous Treatment System for Covid-19, Post-Acute Sequelae of SARS-CoV-2 Infection and Influenza Based on Machine Learning
          • Kunming, Yunnan, China
            Sheng'Ai Traditional Medicine Hospital
          Sep 22, 2023

          COVID-19 Trial (NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine, Prototype/XBB.1.5 Bivalent Vaccine (5 µg))

          Not yet recruiting
          • COVID-19
          • NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine
          • Prototype/XBB.1.5 Bivalent Vaccine (5 µg)
          • (no location specified)
          Aug 4, 2023

          COVID-19 Vaccine, COVID-19 Trial in Bangkok (50 µg Baiya SARS-CoV-2 Vax 2, Placebo)

          Not yet recruiting
          • COVID-19 Vaccine
          • COVID-19
          • 50 μg Baiya SARS-CoV-2 Vax 2
          • Placebo
          • Bangkok, Thailand
            Queen Saovabha Memorial Institute
          May 23, 2023

          Immunogenicity, Safety Trial (Phase II:SWIM816;SARS-Cov-2;, Phase II:SW-BIC-213;SARS-Cov-2;, PhaseIII:SWIM816;SARS-Cov-2;)

          Not yet recruiting
          • Immunogenicity
          • Safety
          • Phase II:SWIM816;SARS-Cov-2;
          • +3 more
          • (no location specified)
          Jun 18, 2023

          COVID-19 Vaccination in Multiple Sclerosis Treated With Immune

          Active, not recruiting
          • Multiple Sclerosis
          • Analysis of cell-mediated and antibody-mediated immunity to SARS-CoV-2 virus
          • Portland, Oregon
            Providence Neurological Specialties West
          Sep 1, 2022

          Quantitative COVID-19 SARS-CoV-2 Antibody Pre and Post

          Completed
          • Laboratory Assessment SARS-CoV-2 Antibody Levels Before and After Surgery for Patients Requiring Cardiopulmonary Bypass
          • SARS-CoV-2 Antibody test
          • Philadelphia, Pennsylvania
            Thomas Jefferson University
          Apr 28, 2022

          COVID-19 Trial in United States (Nasal Swab, Nasopharyngeal swab)

          Recruiting
          • COVID-19
          • Nasal Swab
          • Nasopharyngeal swab
          • Birmingham, Alabama
          • +5 more
          Aug 17, 2022

          Recovering From COVID

          Not yet recruiting
          • SARS CoV 2 Infection
          • Fitbit
          • (no location specified)
          Mar 29, 2022

          COVID-19, SARS-CoV-2 Trial in Moscow, St Petersburg (Biological: AZD3152, Biological: Placebo)

          Not yet recruiting
          • COVID-19, SARS-CoV-2
          • Biological: AZD3152
          • Biological: Placebo
          • Moscow, Russian Federation
          • +5 more
          Sep 26, 2023

          SARS-CoV2 Infection Trial in Flint (General SARS-CoV-2 Communication, Rural-Targeted SARS-CoV-2 Communication)

          Recruiting
          • SARS-CoV2 Infection
          • General SARS-CoV-2 Communication
          • Rural-Targeted SARS-CoV-2 Communication
          • Flint, Michigan
            Flint Journal Building
          Oct 10, 2023

          COVID Vaccine Immunity in Kidney Transplant Recipients

          Withdrawn
          • End Stage Renal Disease
          • Kidney Transplant; Complications
          • Coronavirus (COVID-19) SARS-CoV-2 inSIGHT™ T Cell Immunity Test
          • (no location specified)
          Oct 25, 2022

          SARS-CoV-2 Infection, COVID-19, Coronavirus Trial in Marseille, Nîmes (eBAM Cov Testing)

          Not yet recruiting
          • SARS-CoV-2 Infection
          • +2 more
          • eBAM Cov Testing
          • Marseille, France
          • +1 more
          Oct 23, 2023

          COVID-19 Transmission and Morbidity in Malawi

          Recruiting
          • SARS CoV 2 Infection
          • SARS CoV 2 Vaccination
            • Boston, Massachusetts
            • +1 more
            Aug 6, 2023

            SARS-CoV-2 in Stools Compared to Respiratory Viral Strains.

            Not yet recruiting
            • SARS-CoV-2 Infection
            • Biological assays
            • Vandoeuvre Les Nancy, France
              Schvoerer
            Oct 1, 2022

            LumiraDX SARS-CoV-2 Ag Ultra and LumiraDX SARS-CoV-2 & Flu A/B

            Not yet recruiting
            • SARS-CoV-2
            • +4 more
            • LumiraDx SARS-CoV-2 Ag Ultra
            • LumiraDx SARS-CoV-2 & Flu A/B
            • DeLand, Florida
              Hillcrest Medical Research
            Feb 6, 2023